Stock SNPX SYNAPTOGENIX, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Synaptogenix, Inc.

Equities

SNPX

US87167T3005

Market Closed - Nasdaq
Other stock markets
 04:30:01 2024-07-16 pm EDT 		5-day change 1st Jan Change
4.44 USD +0.23% Intraday chart for Synaptogenix, Inc. -1.33% -34.68%
Jul. 11 Maxim Upgrades Synaptogenix to Buy From Hold, Price Target is $14 MT
Jun. 26 Synaptogenix Announces FDA Authorization of IND Application for Clinical Trial for Bryostatin-1 in Multiple Sclerosis CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
SYNAPTOGENIX, INC.
Other Biotechnology & Medical Research
+0.23%-1.33%-34.68%-81.04% - 5.46M
Neutral
Neutral
Bearish

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. SNPX Stock
  4. Charts Synaptogenix, Inc.
  5. Comparison Chart